13
Views
16
CrossRef citations to date
0
Altmetric
Original Article

The Effects of Chronic Administration of Indomethacin and Misoprostol on Renal Function in Cirrhotic Patients with and without Ascites

, , , , , & show all
Pages 1194-1199 | Received 02 Jan 1995, Accepted 15 Apr 1995, Published online: 08 Jul 2009

References

  • Zipser R D, Radvan G H, Kronborg I J, Duke R, Little TE. Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors. Gastroenterology 1983; 84: 697–703
  • Epstein M, Lifschitz MD. Renal eicosanoids as determinants of renal function in liver disease. Hepatology 1987; 7: 1359–67
  • Arroyo V, Ginès P, Rimola A, Gaya J. Renal function abnormalities, prostaglandins, and effects of nonsteroidal antiinflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis. Am J Med 1986; 81: 10622, Suppl 2B
  • Wong F, Massie D, Hsu P, Dudley F. Dose dependent effect of misoprostol on indomethacin induced renal dysfunction in alcoholic cirrhosis. Hepatology 1991; 14: 134A
  • Fevery J, Van Cutsem E, Nevens F, Van Steenbergen W, Verberckrnoes R, De Groote J. Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin El analogue) and albumin administration. J Hepatol 1990; 11: 153–8
  • Bruix J, Bosch J, Kravetz D, Mastai R, Rod J. Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of liver. Gastroenterology 1985; 88: 430–5
  • Rabinovitz M, Van Thiel DH. Hepatotoxicity of nonsteroidal anti-inflammatory drugs. Am J Gastroenterol 1992; 87: 1696–704
  • Lewis JH. Hepatic toxicity of nonsteroidal anti-inflammatory drugs. Clin Pharmacol 1984; 3: 128–38
  • Boyer T D, Zia P, Reynolds TB. Effect of indomethacin and prostaglandin Al in renal function and plasma renin activity in alcoholic liver disease. Gastroenterology 1979; 77: 215–22
  • Antillon M, Cominelli F, Reynolds T B, Zipser RD. Comparative acute effects of diflunisal and indomethacin on renal function in patients with cirrhosis and ascites. Am J Gastroenterol 1989; 84: 153–5
  • Antillon M, Cominelli F, Lo S, Moran M, Somberg K, Reynolds T B, et al. Effects of oral prostaglandins on indomethacin-induced renal failure in patients with cirrhosis and ascites. J Rheumatol 1990; 20: 46–9, Suppl
  • Wong F, Massie D, Hsu P, Dudley F. Indomethacin-induced renal dysfunction in patients with well-compensated cirrhosis. Gastroenterology 1993; 104: 869–76
  • Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, et al. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981; 27: 213–8
  • Ginès A, Escorsell A, Ginès P, Saló J, Jiménez W, Inglada L, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993; 105: 229–36
  • Pugh R NH, Marray-Lyon M, Dawson J L, Pietroni M C, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646–9
  • Tauxe W N, Maher F T, Taylor WF. Effective renal plasma flow: estimation from theoretical volumes of distribution of intravenously injected 131I-orthoiodohippurate. Mayo Clin Proc 1971; 46: 524–31
  • Gentilini P, Romanelli R G, La Villa G, Maggiore Q, Pesciullesi E, Cappelli G, et al. Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of liver. Gastroenterology 1993; 104: 588–94
  • Epstein M, Levinson R, Sancho J, Haber E, Re R. Characterization of renin-aldosterone system in decompensated cirrhosis. Circ Res 1977; 41: 818–29
  • Ginès A, Salmerón J M, Ginøs P, Arroyo V, Jiménez W, Rivera F, et al. Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure. J Hepatol 1993; 17: 220–6
  • Shields MJ. Misoprostol: new frontiers; benefits beyond the gastrointestinal tract. Scand J Rheumatol 1992; 92: 31–52, Suppl
  • Wong F, Massie D, Hsu P, Dudley F. Dose-dependent effects of oral misoprostol on renal function in alcoholic cirrhosis. Gastroenterology 1994; 106: 658–63
  • Bosch J, Arroyo V, Betriu A, Mas A, Carrilho F, Rivera F, et al. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology 1980; 78: 92–9
  • Arroyo V, Planas R, Gaya J, Deulofeu R, Rimola A, Perez-Ayuso R M, et al. Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion. Eur J Clin Invest 1983; 13: 271–8
  • Schrier R W, Arroyo V, Bernardi M, Henriksen J H, Rodés J. Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151–7
  • Zambraski El, Dunn MJ. Importance of renal prostaglandins in control of renal function after chronic ligation of the common bile duct in dogs. J Lab Clin Med 1984; 103: 549–59
  • Levy M, Wexler M J, Fechner C. Renal perfusion in dogs with experimental hepatic cirrhosis: role of prostaglandins. Am J Physiol 1983; 245: F521–9
  • Boers M, Bensen W G, Ludwin D, Goldsm C H, Tugwell P. Cyclosporine nephrotoxicity in rheumatoid arthritis: no effect of short term misoprostol treatment. J Rheumatol 1992; 19: 534–7
  • Toto RD. The role of prostaglandins in NSAID induced renal dysfunction. J Rheumatol 1991; 18: 22–5, Suppl 28

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.